It belongs to a class of drugs known as triple receptor agonists, acting simultaneously on glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
These aggressions weaken the skin barrier, hastening premature aging signs and increasing skins susceptibility to dryness, breakouts and flare-ups
This model not only has the simplest possible form, but it is also the most generalized/accurate correlation for phase equilibrium monitoring of alcohol/hydrogen binary systems
Glucagon-like receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks
**Minimal Side Effects** GLP-1 shots can come with various side effects, such as nausea, vomiting, and gastrointestinal issues
They may recommend staying at your previous lower dose for the next 4 weeks to give your body more time to adjust